Royal Bank of Canada’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,992
Closed -$17K 7526
2025
Q2
$17K Buy
6,992
+2,771
+66% +$6.79K ﹤0.01% 6326
2025
Q1
$6K Sell
4,221
-5,269
-56% -$8.8K ﹤0.01% 6317
2024
Q4
$17K Buy
9,490
+5,586
+143% +$7.59K ﹤0.01% 6180
2024
Q3
$5K Sell
3,904
-2,401
-38% -$3.25K ﹤0.01% 6515
2024
Q2
$9K Sell
6,305
-634
-9% -$841 ﹤0.01% 6395
2024
Q1
$11K Sell
6,939
-4,453
-39% -$7.14K ﹤0.01% 6180
2023
Q4
$18K Buy
11,392
+6,776
+147% +$10.2K ﹤0.01% 6352
2023
Q3
$10K Buy
+4,616
New +$9.88K ﹤0.01% 6425

Other funds holding THTX

Royal Bank of Canada's THTX Position: Q3 2025 in Review

Royal Bank of Canada sold out of Theratechnologies (THTX) in Q3 2025, closing a stake of 6,992 shares — an estimated $17K sold.

Royal Bank of Canada first reported a position in THTX in Q3 2023 and held it in 8 quarters. The position peaked at $18K in Q4 2023. 10 funds tracked by Wall St. Rank hold THTX as of Q3 2025.

  • Royal Bank of Canada reported no remaining Theratechnologies position as of Q3 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 6,992 Theratechnologies shares in Q3 2025, an estimated $17K.
  • Royal Bank of Canada first reported a position in Theratechnologies in Q3 2023 and held it in 8 quarters.
  • Royal Bank of Canada's Theratechnologies position peaked at $18K in Q4 2023.
  • 10 funds tracked by Wall St. Rank held Theratechnologies as of Q3 2025.

Based on Royal Bank of Canada's 13F filing for Q3 2025, filed 14 Nov 2025.